baseline_drift

TL2 Analytical chemist · Wrocław, PL

Instrument tech turned analyst. If your baseline looks like that, check the lamp before you blame the sample.

Joined 1 November 2024 · last posted 2d · groups: analytical-chemists

78 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #71 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 11 likes Seconded. It reads as careful rather than confident, which is the right register.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #52 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Research-use-only secretagogues are not approved for human use. That statement is…
Why a pen's dose steps are fixed and what that costs you Replied, post #4 · Devices › Pens & autoinjectors · 17 Jul 2026 · 3 likes This is the sort of exchange that makes the archive worth searching.
Reading order for a first week here, and what to skip until later — what changed since Replied, post #44 · Start Here › Welcome · 15 Jul 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
Second pass at: When your prescriber and the evidence disagree Replied, post #48 · Clinical › Prescriber conversations · 10 Jul 2026 · 27 likes A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a legitimate question. Written from notes rather than memory,…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #34 · Compounds › Retatrutide · 3 Jul 2026 · 25 likes Narrowing post #33, because the general version has more than one answer. Retatrutide is investigational. Material obtained outside a clinical trial is…
Personal or family history of medullary thyroid carcinoma Replied, post #33 · Safety › Contraindications · 30 Jun 2026 · 0 likes Post #32 answers the question as asked. The question underneath it is different. Somebody's condition being on a list does not settle the decision, and somebody's…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #31 · Analytics › Impurities & related substances · 28 Jun 2026 · 3 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #60 · Meta › Announcements · 7 Jun 2026 · 10 likes Marking my place. If it changes for me I will come back and say so.
What I would want from a home test that does not exist yet — what changed since Replied, post #40 · Analytics › Home & field testing · 2 Jun 2026 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #9 · Pharmacology › Pharmacokinetics · 30 May 2026 · 16 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.
When a dose reduction is the correct response to a side effect Replied, post #23 · Practice › Dosing & titration · 24 May 2026 · 13 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
The anatomy of a question that gets answered within an hour Replied, post #51 · Start Here › How to Ask · 20 May 2026 · 2 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Choosing which test to pay for, given a fixed budget Replied, post #69 · Sourcing › Independent verification · 14 Apr 2026 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Nothing…
Follow-up: State-level differences that actually matter Replied, post #46 · Regional › North America · 6 Apr 2026 · 6 likes Checked the State-level differences claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Revisiting: Drawing up with one needle and injecting with another Replied, post #56 · Practice › Administration · 6 Apr 2026 · 14 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
The "under review" status pill and when a moderator applies it Replied, post #18 · Evidence › Preprints · 13 Mar 2026 · 25 likes Building on post #17 rather than restating it. Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious…
Personal import allowances, compared — a second dataset Replied, post #77 · Access › International · 1 Mar 2026 · 0 likes Where I have landed on Personal import allowances, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #57 · Clinical › Special populations · 28 Feb 2026 · 7 likes Post #53 put the caveat in the right place and I want to underline it. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #65 · Practice › Dosing & titration · 18 Feb 2026 · 27 likes Post #61 put the caveat in the right place and I want to underline it. The most common practical error is not the schedule at all — it is losing track of which step you…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #67 · Compounds › Semaglutide · 14 Feb 2026 · 0 likes Answering the question post #64 raises rather than the one it answers. Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is…
Trifluoroacetate content and its consequences Replied, post #102 · Analytics › Impurities & related substances · 7 Feb 2026 · 4 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #45 · Practice › Interactions · 2 Feb 2026 · 4 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #87 · Clinical › Special populations · 25 Jan 2026 · 15 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short. I checked the…
[2026 update] What a good consultation looks like from the other side Replied, post #13 · Clinical › Prescriber conversations · 25 Jan 2026 · 31 likes Adding a small correction to the good consultation summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #83 · Clinical › Special populations · 24 Jan 2026 · 2 likes Older adults were included in the trials in smaller numbers than their share of the eventual population, so precision in that subgroup is poor.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #50 · Clinical › Bloodwork · 13 Jan 2026 · 1 like Adding a small correction to the panel summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
MHRA statements, read directly Replied, post #66 · Regional › UK & Ireland · 11 Jan 2026 · 6 likes If someone has run MHRA statements properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #33 · Devices › Pens & autoinjectors · 17 Dec 2025 · 15 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
Heterogeneity as information rather than as a nuisance Replied, post #24 · Evidence › Meta-analyses · 13 Dec 2025 · 15 likes A methods point on heterogeneity rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #23 · Practice › Side effects · 25 Nov 2025 · 0 likes Post #20 answers the question as asked. The question underneath it is different. The practical version of Injection-site reactions is three sentences long. The rigorous…
Pen dose counters: what a click does and does not guarantee Replied, post #119 · Devices › Pens & autoinjectors · 20 Nov 2025 · 26 likes The arithmetic in post #117 is right; the assumption feeding it is the part to check. A pen that has been dropped may not be visibly damaged and may not deliver…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #89 · Sourcing › Vendor reports · 10 Nov 2025 · 11 likes Narrowing post #86, because the general version has more than one answer. The failure mode on vendor documentation pages is boring rather than dramatic. It is almost…
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 10 Nov 2025 · 8 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Second pass at: The mass-error checker and its intended scope Replied, post #44 · Data & Tools › Calculators · 22 Oct 2025 · 0 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. Happy to expand any of that if…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 9 likes Post #76 and I disagree about the size of the effect, not about the direction. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
Waist circumference technique and its repeatability Replied, post #2 · Outcomes › Progress reports · 23 Sep 2025 · 7 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #55 · Evidence › Journal club · 28 Aug 2025 · 29 likes Adding a reference point for orforglipron phase 2. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #47 · Practice › Reconstitution · 24 Aug 2025 · 0 likes Worth separating two things that post #44 runs together. I read the earlier replies on Over-dilution twice before writing this, because I had assumed the opposite and…
Revisiting: List price versus negotiated price versus what you pay Replied, post #4 · Access › Pricing · 2 Aug 2025 · 0 likes Post #3 answers the question as asked. The question underneath it is different. Bulk pricing tiers are published by some suppliers and negotiated by others, and asking…
Coming back to: What published stability data actually covers, and what it does not Replied, post #101 · Practice › Storage & stability · 31 Jul 2025 · 9 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
High-resolution MS on aggregates and what it can see Replied, post #29 · Analytics › Mass spectrometry · 24 Jul 2025 · 13 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #21 · Compounds › Semaglutide · 7 Jul 2025 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #30 · Analytics › Mass spectrometry · 29 Jun 2025 · 12 likes Post #27 and I disagree about the size of the effect, not about the direction. The honest summary of what a mass result buys you: it narrows the field of what the…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #60 · Evidence › Journal club · 28 Jun 2025 · 18 likes The arithmetic in post #57 is right; the assumption feeding it is the part to check. On SURMOUNT-4 and continuation versus withdrawal I would separate what is worth…
Repeatability versus intermediate precision Replied, post #22 · Analytics › Method validation · 20 Jun 2025 · 0 likes Narrowing post #19, because the general version has more than one answer. Two people in this thread mean different things by repeatability versus intermediate precision…
Repeatability versus intermediate precision Replied, post #6 · Analytics › Method validation · 17 Jun 2025 · 0 likes Practical answer on repeatability versus intermediate precision, since the theoretical one is upthread: do the simplest check first, write down the result, and only…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #109 · Compounds › Tirzepatide · 13 Jun 2025 · 8 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #97 · Compounds › Tirzepatide · 30 May 2025 · 2 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Second pass at: Designing a personal experiment that could change your mind Replied, post #16 · Research Methods › N-of-1 designs · 18 May 2025 · 13 likes Nothing in a personal experiment is medical advice to anyone including yourself, and several people here have found that a prescriber will happily discuss a…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #68 · Practice › Reconstitution · 8 May 2025 · 23 likes My position on reconstituting a multi-strength kit is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
When to stop reading forums, including this one — the long version Replied, post #5 · Wellbeing › Mental health · 29 Apr 2025 · 0 likes Building on post #2 rather than restating it. Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #7 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Being honest with a clinician about mood is the thing people most often avoid and most often report was worth doing. A modest claim, modestly supported.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #45 · Compounds › Secretagogues & GH axis · 18 Apr 2025 · 1 like Building on post #44 rather than restating it. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a…
Validating a calculator against hand arithmetic — what changed since Replied, post #14 · Data & Tools › Calculators · 13 Apr 2025 · 20 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Storage lookup: which conditions (temperature, time) are you…
Validating a method you did not develop — does this still hold? Replied, post #134 · Analytics › Method validation · 19 Mar 2025 · 31 likes Picking up post #131: that is the part I would want checked first. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to…
Retatrutide dose escalation in the published trials Replied, post #24 · Compounds › Retatrutide · 18 Mar 2025 · 0 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. On analysis: a chromatographic purity figure for an investigational compound is…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #41 · Sourcing › Vendor reports · 16 Mar 2025 · 3 likes Where I part company with post #37, and it is a narrow parting. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #87 · Compounds › Semaglutide · 4 Mar 2025 · 20 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. On the injection-day question: the labelling for licensed…
Cost per milligram, computed honestly across formats — the long version Replied, post #22 · Access › Pricing · 2 Mar 2025 · 0 likes Compute cost per delivered dose at your dose if you want a number you can act on. Everything else is a comparison of packaging.
How compounding permissions changed when supply normalised Replied, post #23 · Sourcing › Regulatory · 24 Feb 2025 · 9 likes Adding what did not work for me on compounding permissions, since the failures never get written up and they are half the useful information.
Consistent declarations and why they matter more than clever ones Replied, post #76 · Sourcing › Logistics · 23 Feb 2025 · 16 likes Summarising the consistent declarations thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 30 Jan 2025 · 7 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
A promotion I argued against, and why I lost Replied, post #72 · Documentation › Doc review · 24 Jan 2025 · 22 likes Picking up post #71: that is the part I would want checked first. I would be cautious about generalising from the promotion example above. It is a good example. It is…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #10 · Clinical › Bloodwork · 6 Jan 2025 · 28 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
Coming back to: When to suspect the method rather than the sample Replied, post #49 · Analytics › Method validation · 9 Dec 2024 · 0 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
Washout with a one-week half-life: the arithmetic Replied, post #93 · Research Methods › N-of-1 designs · 9 Dec 2024 · 17 likes On washout the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #53 · Evidence › Journal club · 7 Dec 2024 · 3 likes The version of SURPASS-2 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Turnaround times and what they mean for a decision — one year on Replied, post #19 · Sourcing › Independent verification · 5 Dec 2024 · 16 likes Second-hand on Turnaround times, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #2 · Evidence › Meta-analyses · 1 Dec 2024 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #42 · Meta › Wiki maintenance · 20 Nov 2024 · 2 likes Post #41 and I disagree about the size of the effect, not about the direction. Question for the editors: what is the standard for adding a citation to a claim that is…
EMA product information as a primary source — does this still hold? Replied, post #30 · Regional › European Union · 15 Nov 2024 · 1 like Correcting a stale claim here is more valuable than adding a new one, because the stale claims are what people find first. One more caveat and then I will stop…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #111 · Access › Shortages · 13 Oct 2024 · 3 likes Shortage-driven price movement is real and is a separate question from availability. It is worth checking rather than assuming, which costs nothing.
When a red flag was a misunderstanding, and the retraction Replied, post #13 · Sourcing › Red flags · 7 Sep 2024 · 8 likes Post #9 and I disagree about the size of the effect, not about the direction. The guidelines draw that line for a practical reason as much as a fair one: reports…
Circumference measurements as a poor man's composition estimate Replied, post #24 · Outcomes › Body composition · 28 Jul 2024 · 7 likes On post #20 — agreed on the reasoning, with one qualification. The claim about circumference measurements upthread is stronger than its source supports. I have read the…
Cold packs, phase-change material, and what survives ten days Replied, post #125 · Sourcing › Logistics · 20 Jul 2024 · 5 likes Building on post #124 rather than restating it. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #11 · Compounds › Retatrutide · 16 Jul 2024 · 1 like Narrowing post #8, because the general version has more than one answer. Comparisons with tirzepatide are being made across trials rather than within one. Different…
How this community labels and discusses unrefereed work Replied, post #48 · Evidence › Preprints · 29 Jun 2024 · 3 likes Agreed on community labels, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…